“Additionally, for the purpose of evaluating safety and efficacy, vaccine clinical trials often use an aluminium-containing placebo, either containing the same or greater amount of aluminum as the test vaccine [48-51]. Without exception, these trials report a comparable rate of adverse reactions between the placebo and the vaccine group (for example, 63.7% vs 65.3% of systemic events and 1.7% vs 1.8% of serious adverse events respectively [51]). According to the U.S. Food and Drug Administration (FDA), a placebo is “an inactive pill, liquid, or powder that has no treatment value” [52]. The well-established neurotoxic properties of aluminium (Table 1) therefore suggest that aluminum cannot constitute as a valid placebo.
In spite of these above data, newborns, infants and children up to 6 months of age in the U.S. and other developed countries receive 14.7 to 49 times more than the FDA safety limits for aluminum from parenteral sources from vaccines through mandatory immunization programs (Table 2). Specifically, 2-month old children in U.K., U.S., Canada and Australia routinely receive as much as 220 to 245 μg/kg bw of aluminum per vaccination session (Table 2), a burden equivalent to 34 standard adult-dose injections of hepatitis B vaccine (Table 3). Similarly, newborns at birth receive 73.5 μg Al/kg bw/day from a single hepatitis B vaccine, which is a dose equivalent to 10 standard adult-dose injections of hepatitis B vaccine in a single day (Table 3). Whether such doses of aluminum are safe even for adults is not known."
CONCLUSIONS
“Aluminum in various forms can be toxic to the nervous system. The widespread presence in the human environment may underlie a number of CNS disorders. The continued use of aluminum adjuvants in various vaccines for children as well as the general public may be of significant concern. In particular, aluminum presented in this form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus have profound and widespread adverse health consequences. The widely accepted notion of aluminum adjuvant safety does not appear to be firmly established in the scientific literature and, as such, this absence may have lead to an erroneous conclusions regarding the significance of these compounds in the etiologies of many common neurological disorders. Furthermore, the continued use of aluminum-containing placebos in vaccine clinical trials may have lead to an underestimation of the true rate of adverse outcomes associated with aluminum-adjuvanted vaccines. In our opinion, a comprehensive evaluation of the overall impact of aluminum on human health is overdue. Such an evaluation should include studies designed to determine the short and long-term impacts of dietary aluminum as well as the potential impacts in different age groups of exposure to adjuvant aluminum alone and in combination with other potentially toxic vaccine constituents (e.g., formaldehyde, formalin, mercury, phenoxyethanol, phenol, sodium borate, polysorbate 80, glutaraldehyde). For the latter, until vaccine safety can be comprehensively demonstrated by controlled independent long- term studies that examine the impact on the nervous system in detail, many of those already vaccinated as well as those currently receiving injections may be at risk for health complications that exceed the potential benefits that vaccine prophylaxis may provide. The issue of aluminum adjuvanted vaccine safety is especially pertinent in light of the legislation which might mandate vaccination regimes for civilian populations (e.g., the Biodefense and Pandemic Vaccine and Drug Development Act of 2005). Whether the risk of protection from a dreaded disease outweighs the risk of toxicity from its presumed prophylactic agent is a question that demands far more rigorous scrutiny than has been provided to date.”
Rowen Comments:
I’ve done some calculations as follows:
First, we turn to the maximum permitted Al for parenteral nutrition in the code of Federal regulations: 25 mcg/L (http://www.accessdata.fda.gov/…/cdrh/c…/cfcfr/CFRSearch.cfm…) and the amount of aluminum therein must appear on the package insert. Consider this amount is for an average 70 kg (155 lbs) adult. If we divide just by weight that 25 mcg by 155 pounds, that nets 0.16 mcg permissible per pound in the IV fluid.
Consider a baby at 7 pounds. That would net 0.16 x 7 lbs = 112 mcg permitted level for parenteral IV therapy. This also doesn’t figure that a baby doesn’t have an adequate blood brain barrier and that Al is known to damage the BBB. A baby’s Al exposure should be far, far less.
Now, let’s turn to what’s in vaccines (http://vaxtruth.org/2011/08/vaccine-ingredients/):
So how much aluminum is in the vaccines that are routinely given to children?
• Hib (PedVaxHib brand only) – 225 mcg per shot
• Hepatitis B – 250 mcg
• DTaP – depending on the manufacturer, ranges from 170 to 625 mcg
• Pneumococcus – 125 mcg
• Hepatitis A – 250 mcg
• HPV – 225 mcg
• Pentacel (DTaP, HIB and Polio combo vaccine) – 330 mcg
Pediarix (DTaP, Hep B and Polio combo vaccine) – 850 mcg
We can clearly see that aluminum given to children in one injection at birth is more than double the FDA permitted level in IV fluid. And consider the additional aluminum given in significant pulses. A FB follower sent me information that the FDA IM limit is 250 mug. We clearly see that the vaccines are pushing the IM limit as well and in BABIES!
Questions for all of you:
1.How is it that babies aren’t afforded the same safety precautions against aluminum in vaccines as adults are in IV fluids when we know they have an immature immune system, a porous blood brain barrier, etc?
2. How is it that vaccine safety studies are conducted against placebo consisting of toxic adjuvants? Of course they are “proven” safe!
You can thank your nearest Pharma company for this terrific piece of overt medical fraud.()
